In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.
D000362:Agar; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D013210:Staphylococcus / Q000145:classification / Q000187:drug effects* / Q000254:growth & development; D013291:Streptococcus / Q000145:classification / Q000187:drug effects* / Q000254:growth & development; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D003470:Culture Media; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D000362:Agar; D008034:Lincomycin; D013752:Tetracycline; D010400:Penicillin G; D010068:Oxacillin